Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

TP53 mutation promotes diffuse large B-cell lymphoma progression via mediating lactylation of ATP5E at Lys44

Linquan Zhan, Chenyang Jiang, Tiange Lu, Hua Wang, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 5037.

https://doi.org/10.1182/blood-2025-5037

Published: 2025

Journal Articles

Development and validation of a novel pathologically-based prognostic model for primary central nervous system lymphoma

Yupiao Feng, Xinting Hu, Yutang Li, Huiting Qu, Dai Yuan, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 5446.

https://doi.org/10.1182/blood-2025-5446

Published: 2025

Journal Articles

Dioscin suppresses the progression of diffuse large B-cell lymphoma by modulating acaca-dependent histone H3K27 acetylation and inducing mitophagy

Qianqian Guo, Xiaoli Zhou, Xiangxiang Zhou, Shunfeng Hu

Blood (2025) 146 (Supplement 1): 1523.

https://doi.org/10.1182/blood-2025-1523

Published: 2025

Journal Articles

Exploring the disease impact of plasma metabolites on marginal zone lymphoma based on mendelian randomization

Yupiao Feng, Xinting Hu, Yutang Li, Hua Wang, Kang Lu, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 7122.

https://doi.org/10.1182/blood-2025-7122

Published: 2025

Journal Articles

Establishment of a prognostic model for diffuse large B-cell lymphoma based on mitochondrial energy metabolism-related genes

Ganyu Feng, Yupiao Feng, Yutang Li, Mengyuan He, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 7086.

https://doi.org/10.1182/blood-2025-7086

Published: 2025

Journal Articles

The dual-target molecular glue degrader INNO-235 effectively mediates the degradation of GSPT1 and CK1α, and exhibits potent anti-tumor activity in TP53 mutant burkitt lymphoma

Minghao Sun, Shi Feng, Qingbo Hao, Haiyang Wang, Ran Kong, Cong Wang, Michael Haughey, Derek Mendy, Patrick Papa, Weilin Xie, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 5091.

https://doi.org/10.1182/blood-2025-5091

Published: 2025

Journal Articles

Single-cell and spatial transcriptomics analyses decipher malignant B cell heterogeneity and immunosuppressive microenvironment in primary central nervous system lymphoma

Cong Wang, Tiange Lu, Xiangrong Zheng, Ran Kong, Mei Ding, Xiaohui Sui, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 1762.

https://doi.org/10.1182/blood-2025-1762

Published: 2025

Journal Articles

A predictive model for treatment failure in CLL/SLL patients receiving BTK inhibitor: A multi-center retrospective study

Yutang Li, Xinting Hu, Yupiao Feng, Ling Wang, Xiaoqian Liu, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 7423.

https://doi.org/10.1182/blood-2025-7423

Published: 2025

Journal Articles

Arginine deprivation activates immunogenic cell death and enhances anti-tumor immunity in diffuse large B-cell lymphoma

Guangcai Zhong, Xinyu Yang, Tiange Lu, Minghao Sun, Shi Feng, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 3298.

https://doi.org/10.1182/blood-2025-3298

Published: 2025

Journal Articles

Efficacy and safety of RCD pulse regimen for acquired Hemophilia A

Xianghua Wang, Peipei Li, Ya Zhang, Zhumei Zhan, Cheng Zhang, Changqing Zhen, Juan Fan, Xiaosheng Fang, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 1314.

https://doi.org/10.1182/blood-2025-1314

Published: 2025

Journal Articles

RNF20 promotes the progression of diffuse large B-cell lymphoma through regulating ubiquitination-dependent Phase separation of fus

Qianqian Guo, Xiaoli Zhou, Xiangxiang Zhou, Shunfeng Hu

Blood (2025) 146 (Supplement 1): 6816.

https://doi.org/10.1182/blood-2025-6816

Published: 2025

Journal Articles

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Blood (2025) 146 (Supplement 1): 1878.

https://doi.org/10.1182/blood-2025-1878

Published: 2025

Journal Articles

Thyroid diffuse large B-cell lymphoma in China: Multicenter study of diagnosis, clinical features, treatment efficacy, prognostic factors, and genomic alterations

Blood (2025) 146 (Supplement 1): 1902.

https://doi.org/10.1182/blood-2025-1902

Published: 2025

Journal Articles

ST6GALNAC4 promotes DLBCL progression by regulating ldha sialylation to enhance glycolysis and lactate production

Anqi Zhou, Xinyu Yang, Guangcai Zhong, Ran Kong, Yue Li, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 3309.

https://doi.org/10.1182/blood-2025-3309

Published: 2025

Journal Articles

An orally bioavailable and dual-targeting GSPT1 and CK1α molecular glue degrader targets double-hit lymphoma cells

Shi Feng, Minghao Sun, Qingbo Hao, Ran Kong, Michael Haughey, Derek Mendy, Patrick Papa, Weilin Xie, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 3308.

https://doi.org/10.1182/blood-2025-3308

Published: 2025

Journal Articles

The Treatment Pathways, Patient Characteristics and Outcomes in Patients with CD30-Expressing Lymphoma from China: A Multi-Center, Non-Interventional, Retrospective Study

Yi Miao, Wenyu Li, Kaiyang Ding, Fei Li, Xiaojing Yan, Xiaoxi Zhou, Caixia Li, Guohui Cui, Liqun Zou, Bing Xiu, Xiangxiang Zhou, Liansheng Zhang, Fuling Zhou, Hongmei Jing, Jianli Wang, Ziheng Guo, Jianyong Li

Blood (2024) 144 (Supplement 1): 6372.

https://doi.org/10.1182/blood-2024-201339

Published: 2024

Journal Articles

Causal Relationship between Gut Microbiota, Derived Metabolites, and Diffuse Large B-Cell Lymphoma: A Two-Sample Mendelian Randomization Study

Ganyu Feng, Guangcai Zhong, Cong Wang, Ran Kong, Jianhong Wang, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 6274.

https://doi.org/10.1182/blood-2024-209446

Published: 2024

Journal Articles

Comprehensive Analysis of Sialylation-Related Signature and Development of a Novel Prognostic Model in Diffuse Large B-Cell Lymphoma

Ran Kong, Cong Wang, Guangcai Zhong, Ganyu Feng, Jiarui Liu, Yang Han, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 6241.

https://doi.org/10.1182/blood-2024-199162

Published: 2024

Journal Articles

ST6GALNAC4 Promotes Diffuse Large B-Cell Lymphoma Progression Via Mediating Sialylation of Bmpr-1B at Thr24

Yu Zhang, Cong Wang, Tiange Lu, Ran Kong, Liemei Lv, Mei Ding, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 833.

https://doi.org/10.1182/blood-2024-210107

Published: 2024

Journal Articles

A Highly Selective and Orally Bioavailable CK1α Molecular Glue Degrader Targets B-Cell Lymphoma Cells

Ran Kong, Shi Feng, Cong Wang, Qingbo Hao, Yu Zhang, Jingjing Han, Xiaoyu Xie, Haiyang Wang, Jan Elsner, Derek Mendy, Michael Haughey, Paul Krenitsky, Veronique Plantevin-Krenitsky, Patrick Papa, Frank Mercurio, Weilin Xie, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 956.

https://doi.org/10.1182/blood-2024-208315

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

TP53 mutation promotes diffuse large B-cell lymphoma progression via mediating lactylation of ATP5E at Lys44

Development and validation of a novel pathologically-based prognostic model for primary central nervous system lymphoma

Dioscin suppresses the progression of diffuse large B-cell lymphoma by modulating acaca-dependent histone H3K27 acetylation and inducing mitophagy

Exploring the disease impact of plasma metabolites on marginal zone lymphoma based on mendelian randomization

Establishment of a prognostic model for diffuse large B-cell lymphoma based on mitochondrial energy metabolism-related genes

The dual-target molecular glue degrader INNO-235 effectively mediates the degradation of GSPT1 and CK1α, and exhibits potent anti-tumor activity in TP53 mutant burkitt lymphoma

Single-cell and spatial transcriptomics analyses decipher malignant B cell heterogeneity and immunosuppressive microenvironment in primary central nervous system lymphoma

A predictive model for treatment failure in CLL/SLL patients receiving BTK inhibitor: A multi-center retrospective study

Arginine deprivation activates immunogenic cell death and enhances anti-tumor immunity in diffuse large B-cell lymphoma

Efficacy and safety of RCD pulse regimen for acquired Hemophilia A

RNF20 promotes the progression of diffuse large B-cell lymphoma through regulating ubiquitination-dependent Phase separation of fus

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Thyroid diffuse large B-cell lymphoma in China: Multicenter study of diagnosis, clinical features, treatment efficacy, prognostic factors, and genomic alterations

ST6GALNAC4 promotes DLBCL progression by regulating ldha sialylation to enhance glycolysis and lactate production

An orally bioavailable and dual-targeting GSPT1 and CK1α molecular glue degrader targets double-hit lymphoma cells

The Treatment Pathways, Patient Characteristics and Outcomes in Patients with CD30-Expressing Lymphoma from China: A Multi-Center, Non-Interventional, Retrospective Study

Causal Relationship between Gut Microbiota, Derived Metabolites, and Diffuse Large B-Cell Lymphoma: A Two-Sample Mendelian Randomization Study

Comprehensive Analysis of Sialylation-Related Signature and Development of a Novel Prognostic Model in Diffuse Large B-Cell Lymphoma

ST6GALNAC4 Promotes Diffuse Large B-Cell Lymphoma Progression Via Mediating Sialylation of Bmpr-1B at Thr24

A Highly Selective and Orally Bioavailable CK1α Molecular Glue Degrader Targets B-Cell Lymphoma Cells

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only